DC for vaccination against B-cell lymphoma were pulsed with trioma cells thereby combining antigenic polyvalency and targeting of tumor-derived Ag to FcγR expressed on DC. This evidence concerns the gene FCGR2A and B-cell non-Hodgkin lymphoma.